Naloxone shortage goes national in wave of opioid overdose
Public trust in a federal access program for the overdose drug Naloxone has been shaken after more than a year of shortages ...
Healthy Returns: Why people quit weight loss, diabetes drugs within one year
A new study examines how cost, side effects, and other factors influence whether people stop GLP-1s, while Noom cuts staff to ...
FDA Approves the First Non-Opioid Pain Medicine in 20 Years
The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and represent the first new class of pain medications in 20 years—and the first non ...
2 Ultra-High-Yield Dividend Stocks That Are No-Brainer Buys in February
These sensational income stocks -- sporting an average yield of 6.15% -- can fatten investors' pocketbooks for a long time to ...
Trump in Palm Beach: Tariffs, attack on ISIS in Somalia, Venezuela deal and a little golf
The military action was overshadowed by Trump's announcement that he imposed 25% tariffs on goods being imported into the ...
U.S. FDA approves Supernus' drug-device combination for Parkinson's disease
The U.S. Food and Drug Administration has approved Supernus Pharmaceuticals' drug-device combination to treat movement-related symptoms of Parkinson's disease, the drugmaker said on Tuesday.
World Bank10h
Drug-Resistant Infections: A Threat to Our Economic Future
Drug-resistant infections occur when pathogens change in ways that render antimicrobial drugs ineffective. As a result, the pathogens survive and continue to spread. When infections are treatable with ...